C4XD names Piers Morgan, CEO
This article was originally published in Scrip
Executive Summary
C4X Discovery, a drug discovery and design spin-out firm from the University of Manchester, has appointed Piers Morgan chief executive officer. Mr Morgan has also been appointed a member of the Manchester, UK-based company's board of directors. He succeeds Dr Sam Williams, who will resume his previous role as a non-executive director of the company. Prior to joining C4XD Mr Morgan was chief financial officer at UniQure, a gene therapy company.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.